Atlas Trials

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Clinical trial NCT00053105 · UNKNOWN

Trial details

NCT number
NCT00053105
Sponsor
Theradex
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma
Start date
2002-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.